Some 80% of Actavis Romania sales come from oncology medicine, the rest being generated by cardiovascular and central nervous system medicine.
The Actavis group holds one oncology medicine production unit in Bucharest, Sindan Pharma, which it bought for EUR147.5 million in March 2006.
The Actavis group has some 10,000 employees in 40 countries and it has posted overall sales of EUR1.7 billion last year. This year, the group targets sales of EUR2 billion.